What is the appropriate treatment for an acute eczema flare?

Treatment of Acute Eczema Flare

For an acute eczema flare, immediately initiate topical corticosteroids as the mainstay of treatment, combined with liberal emollient use and consideration of secondary bacterial infection. 1

Core Treatment Algorithm

Step 1: Assess Flare Severity and Rule Out Complications

Before treating, evaluate for:

• Secondary bacterial infection (most commonly Staphylococcus aureus) - look for weeping, crusting, pustules, or failure to respond to standard therapy 1
• Eczema herpeticum - multiple discrete vesicles and erosions requiring urgent oral or IV acyclovir 1
• Contact dermatitis - new allergen exposure causing deterioration in previously stable disease 1

Step 2: Immediate Flare Management

Topical Corticosteroids - The cornerstone of flare treatment 1:

• Apply twice daily (no more frequently) 1
• Use the least potent preparation required to control the eczema 1
• Consider patient age, treatment site, and disease extent when selecting potency 1
• For moderate-to-severe flares: use potent or very potent preparations for limited periods only 1
• For sensitive areas (face, flexures): consider lower potency or alternative agents 2

Emollients - Essential concurrent therapy 1:

• Apply liberally and frequently throughout the day 1
• Most effective when applied after bathing 1
• Continue during corticosteroid treatment - do not stop 3
• Provide adequate quantities (patients often under-use due to insufficient prescribing)

Step 3: Adjunctive Therapies for Severe Flares

Wet Wrap Therapy - For moderate-to-severe flares 2:

• Apply topical corticosteroid, then emollient
• Cover with wet layer, then dry layer
• Particularly effective for acute exacerbations

Sedating Antihistamines - Limited role 1:

• Use only for short-term adjuvant treatment during severe pruritus
• Value resides in sedative properties for nighttime use only 1
• Avoid daytime use 1
• Non-sedating antihistamines have no value in atopic eczema 1

Step 4: Treat Secondary Infection if Present

Antibiotics - Only for overt secondary bacterial infection 1:

• Flucloxacillin - first-line for S. aureus 1
• Erythromycin - for penicillin allergy or flucloxacillin resistance 1
• Phenoxymethylpenicillin - if β-hemolytic streptococci isolated 1

Eczema Herpeticum - Medical emergency 1:

• Oral acyclovir given early in disease course
• IV acyclovir for ill, febrile patients
• Send viral swabs and electron microscopy if suspected 1

Common Pitfalls to Avoid

Steroid Phobia - A major barrier to effective treatment 1:

• Undertreatment is more common than overtreatment
• Patient/parent fears often traced to inadequate education about benefits vs. risks
• Explain clearly: appropriate topical corticosteroid use is safe when following guidelines
• The main risk (pituitary-adrenal suppression) occurs primarily with very potent preparations used extensively 1

Inadequate Emollient Use 4:

• Parents frequently under-treat flares with topical corticosteroids
• Emollient use must be maintained even during active treatment
• Prescribe sufficient quantities - inadequate amounts lead to poor adherence

Inappropriate Antihistamine Use 1:

• Non-sedating antihistamines provide no benefit
• Sedating antihistamines only useful at night for severe pruritus
• Tachyphylaxis reduces effectiveness over time

Transition to Maintenance

Once flare is controlled:

• Stop topical corticosteroids for short periods when possible 1
• Consider proactive maintenance therapy with medium-potency topical corticosteroids 2 times/week to prevent relapse 2
• Continue daily emollient use indefinitely 1
• Consider topical calcineurin inhibitors (tacrolimus, pimecrolimus) for maintenance, especially in sensitive areas 2

When to Escalate

Refer or consider advanced therapy if:

• No response to optimized first-line treatment after 2 weeks
• Recurrent severe flares despite maintenance therapy
• Suspected contact dermatitis or other complicating diagnosis 1
• Need for systemic corticosteroids (should be avoided except for severe cases to "tide over" acute crises) 1

The evidence strongly supports this stepwise approach, with topical corticosteroids demonstrating high-certainty evidence for efficacy 2. While newer agents like crisaborole, ruxolitinib, and dupilumab exist 2, 5, they are not first-line for acute flare management and are reserved for maintenance or refractory disease.